Nxstage Medical (Nasdaq: NXTM) reported earnings on Feb. 28. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Dec. 31 (Q4), Nxstage Medical beat expectations on revenues and exceeded expectations on earnings per share.

Compared to the prior-year quarter, revenue increased. GAAP loss per share dropped.

Margins grew across the board.

Revenue details
 Nxstage Medical recorded revenue of $65.0 million. The 13 analysts polled by S&P Capital IQ hoped for revenue of $63.5 million on the same basis. GAAP reported sales were 14% higher than the prior-year quarter's $57.0 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at -$0.04. The 11 earnings estimates compiled by S&P Capital IQ averaged -$0.05 per share. GAAP EPS were -$0.04 for Q4 versus -$0.08 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 39.0%, 190 basis points better than the prior-year quarter. Operating margin was -2.9%, 270 basis points better than the prior-year quarter. Net margin was -3.6%, 440 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $63.8 million. On the bottom line, the average EPS estimate is -$0.05.

Next year's average estimate for revenue is $269.0 million. The average EPS estimate is -$0.11.

Investor sentiment
 The stock has a three-star rating (out of five) at Motley Fool CAPS, with 140 members out of 173 rating the stock outperform, and 33 members rating it underperform. Among 48 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 40 give Nxstage Medical a green thumbs-up, and eight give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Nxstage Medical is outperform, with an average price target of $17.00.

Is Nxstage Medical the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.